News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cantrell Drug Company Updates FDA Registration to 503B Outsourcing Facility


1/24/2014 10:35:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LITTLE ROCK, Ark.--(BUSINESS WIRE)--Cantrell Drug Company today announced amendment of its U.S. Food and Drug Administration (FDA) registration to include the new 503B “compounding outsourcing facility” designation established under the recently passed Drug Quality and Security Act so that it can continue to serve patients nationwide with sterile medications that meet the most exacting quality standards.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES